JPS60233105A - 診断試薬用ラテツクスの製造方法 - Google Patents
診断試薬用ラテツクスの製造方法Info
- Publication number
- JPS60233105A JPS60233105A JP8989784A JP8989784A JPS60233105A JP S60233105 A JPS60233105 A JP S60233105A JP 8989784 A JP8989784 A JP 8989784A JP 8989784 A JP8989784 A JP 8989784A JP S60233105 A JPS60233105 A JP S60233105A
- Authority
- JP
- Japan
- Prior art keywords
- latex
- suspension
- styrene
- emulsifier
- persulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004816 latex Substances 0.000 title claims abstract description 86
- 229920000126 latex Polymers 0.000 title claims abstract description 86
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 238000000034 method Methods 0.000 claims abstract description 25
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 21
- 239000002245 particle Substances 0.000 claims abstract description 20
- 239000000725 suspension Substances 0.000 claims abstract description 12
- 239000003999 initiator Substances 0.000 claims abstract description 8
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 7
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical class [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229920000642 polymer Polymers 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims description 8
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 238000012360 testing method Methods 0.000 abstract description 21
- 230000004520 agglutination Effects 0.000 abstract description 16
- 230000005484 gravity Effects 0.000 abstract description 10
- 238000006116 polymerization reaction Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 abstract description 3
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 abstract description 2
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 abstract description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 230000000621 autoagglutination Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 28
- 239000000427 antigen Substances 0.000 description 20
- 102000036639 antigens Human genes 0.000 description 20
- 108091007433 antigens Proteins 0.000 description 20
- 238000004220 aggregation Methods 0.000 description 15
- 230000002776 aggregation Effects 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 230000035931 haemagglutination Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 238000011891 EIA kit Methods 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- -1 antiserum Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- SMYMJHWAQXWPDB-UHFFFAOYSA-N (2,4,5-trichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl SMYMJHWAQXWPDB-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Landscapes
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8989784A JPS60233105A (ja) | 1984-05-04 | 1984-05-04 | 診断試薬用ラテツクスの製造方法 |
| US06/710,234 US4605686A (en) | 1984-03-13 | 1985-03-11 | Latex for immunoserological tests and a method for the production of the same |
| ES541181A ES8700675A1 (es) | 1984-03-13 | 1985-03-12 | Un metodo de producir un latex para ensayos inmunoserologi- cos |
| EP85301683A EP0158443B1 (en) | 1984-03-13 | 1985-03-12 | A latex for immunoserological tests and a method of producing the same |
| DE8585301683T DE3585045D1 (de) | 1984-03-13 | 1985-03-12 | Ein latex fuer immunoserologische teste und ein verfahren zu seiner herstellung. |
| CA000476291A CA1250805A (en) | 1984-03-13 | 1985-03-12 | Latex for immunoserological tests and a method for the production of the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8989784A JPS60233105A (ja) | 1984-05-04 | 1984-05-04 | 診断試薬用ラテツクスの製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60233105A true JPS60233105A (ja) | 1985-11-19 |
| JPH0149367B2 JPH0149367B2 (enrdf_load_stackoverflow) | 1989-10-24 |
Family
ID=13983525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8989784A Granted JPS60233105A (ja) | 1984-03-13 | 1984-05-04 | 診断試薬用ラテツクスの製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60233105A (enrdf_load_stackoverflow) |
-
1984
- 1984-05-04 JP JP8989784A patent/JPS60233105A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0149367B2 (enrdf_load_stackoverflow) | 1989-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4313734A (en) | Metal sol particle immunoassay | |
| CN110007074B (zh) | 用于检测c反应蛋白的试剂盒、其制备方法及用途 | |
| US4605686A (en) | Latex for immunoserological tests and a method for the production of the same | |
| JPWO2003005031A1 (ja) | 測定試薬用担体粒子ラテックス及び測定試薬 | |
| US3564089A (en) | Diagnostic reagent for syphilis | |
| US4690906A (en) | Nephelometric determination of HBs antigen with antibody-containing microparticles | |
| JPH02194360A (ja) | カルボキシル基含有重合体を含む免疫化学試験用剤 | |
| WO2018043584A1 (ja) | 異なる方式で抗原を固定化した抗原担持不溶性担体粒子を用いる抗体測定法、抗体測定用試薬 | |
| JP2682697B2 (ja) | 免疫測定試薬および免疫測定法 | |
| JPS60233105A (ja) | 診断試薬用ラテツクスの製造方法 | |
| KR101690803B1 (ko) | 항인지질 항체 측정 시약에 사용하는 불용성 담체, 항인지질 항체 측정 시약, 및 항인지질 항체의 측정 방법 | |
| JPS60192262A (ja) | 免疫凝集反応に用いるための担体 | |
| JPS60192706A (ja) | 診断試薬用ラテツクスの製造方法 | |
| JPH0527825B2 (enrdf_load_stackoverflow) | ||
| JPS60258207A (ja) | 診断試薬用ラテックス | |
| JPS5850645B2 (ja) | ラテツクスの製造方法 | |
| US4403040A (en) | Diagnostic test for the detection of a specific tumor antigen with CoA-SPC | |
| JPS62218867A (ja) | 免疫試薬用ラテツクス | |
| JPS6116943B2 (enrdf_load_stackoverflow) | ||
| JPS5834486B2 (ja) | 診断試薬用ラテツクスの製造方法 | |
| JPH0745525B2 (ja) | 診断試薬用塩化ビニル重合体ラテックスおよびその製造方法 | |
| JPS59179609A (ja) | 診断試薬用ラテツクスの製造方法 | |
| JPH0745524B2 (ja) | 診断試薬用塩化ビニル重合体ラテックスおよびその製造方法 | |
| JPS6366464A (ja) | 診断試薬用担体ラテツクス | |
| JP2001289854A (ja) | 高分子球状体、免疫学的測定試薬及び免疫測定法 |